Abstract:Objective: There is a lack of data relating to vaccination of children with special health care needs (CSHCN) and its influencing factors in China. We investigated the disease spectrum of CSHCN at the Vaccination Consultation Clinic in Zhejiang province as well as the underlying factors of vaccination recommendations of these children. Methods: In this study, we retrospectively analyzed the data of 4,525 CSHCN, who visited to our clinic for a vaccination consultation from January 1, 2016 to May 30, 2018. Descriptive data were presented as mean ± standard deviation (SD) and percentages. Multivariate analysis was performed with non-conditional bivariate logistic regression to identify the underlying factors of vaccination recommendations. Subsequent information regarding the following vaccination and the occurrence of AEFI were also collected and analyzed. Results: The main diseases consulted were those relating to the circulatory and nervous systems as well as neonatal diseases. The distribution of diseases varied by age: 53.6% infants under 12 months were counseled for circulatory system diseases, while 44.6% children aged 12~24 months and 54.7% children over 25 months were counseled for nervous system diseases. According to the evaluation reports issued by the consultation clinic, 75.0% of CSHCN were recommended to be vaccinated normally, 21.2% were recommended to defer specific vaccination, while only 3.8% were recommended to defer all vaccinations. In logistic regression analysis, age, history of adverse events following immunization (AEFI) and the number of diseases combined were all strong correlative factors for vaccination recommendations. Children who were aged over 25-month-old (OR = 1.34, 95%CI: 1.11–1.61) or had a history of AEFI (OR = 3.77, 95%CI: 2.83~5.01) or those who had numerous diseases combined (OR = 2.00, 95%CI: 1.46~2.75) tended to have a higher rate of deferred vaccination recommendation. Among those CSHCN who received nationally-recommended vaccines, the estimated AEFI rate was 24.29/100 000. No uncommon or rare serious adverse reactions were detected. Conclusion: Age, history of AEFI, and the number of diseases combined were important factors that affected the vaccination recommendations of CSHCN. Most CSHCN can be safely vaccinated according to the nationally-recommended schedule.

Surveillance and analysis on the suspected adverse events following immunization in Haidian District, Beijing City in 2012

Analysis on surveillance of rare vaccine reaction following immunization in Haidian district of Beijing ,2009-2013

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020

Analysis on surveillance of adverse effects following immunization in Jiangxi from 2005 to 2010

Analysis on the Running Situation and Results of Surveillance System of Adverse Events Following Immunization in Jiangxi Province, during 2005-2008

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China

The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015–2018

Post-Marketing Surveillance of Adverse Events Following Immunization with Haemophilus Influenzae Type b Conjugate Vaccine - China, 2010-2021

Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019–2022

Analysis on the Adverse Events Following Immunization after Measles Vaccine Supplementary Immunization Activity in Anhui Province in 2009

Analysis on 124 Cases Of(suspected)adverse Events Following Immunization of Hepatitis B Vaccine Reported in Documents

STUDY ON THE ADVERSE EVENTS FOLLOWING IMMUNIZATION AFTER THE MEASLES VACCINE FOLLOW-UP IMMUNIZATION IN JIANGXI PROVINCE

Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017

Adverse Events Following Immunization of H1N1 Vaccine in 160 Children

Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study.

Incomplete Vaccination among Children with Special Health Care Needs in Zhejiang, China: Analysis of Retrospective Data

Surveillance for Adverse Events Following Immunization With COVID-19 Vaccines in Dalian, China

Surveillance of adverse events following varicella vaccine immunization in Jiangsu province, China from 2017 to 2023

Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study

Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China

Analysis of Adverse Events Post-13-Valent Pneumococcal Vaccination among Children in Hangzhou, China